Brivaracetam Impurity C is an impurity associated with Brivaracetam, forming during synthesis or storage conditions.

Regulatory authorities mandate monitoring impurities like Brivaracetam Impurity C to ensure the safety and effectiveness of Brivaracetam formulations.

It forms as a by-product under specific synthesis or storage conditions, such as varying temperature or humidity.

Proper storage conditions and regular quality checks help manage and minimize the formation of this impurity.

GC-MS, LC-MS, and HPLC-MS are common methods for the accurate detection and profiling of Brivaracetam Impurity C.

Chemicea provides COA, H-NMR, MASS, HPLC, and TGA reports as standard, with additional reports like CNMR, IR, UV, DEPT, Water content, and CHNS available upon request.

Yes, Chemicea’s documentation meets standards required by major regulatory agencies such as USFDA, EMA, ANVISA, TGA, and PMDA.

It is stable for shipping at room temperature, with specific storage guidelines provided in the COA.

Yes, Chemicea offers both standard and customized pack sizes to meet specific client requirements.

Chemicea supplies Brivaracetam Impurity C as a reference standard, aiding in regulatory compliance, method validation, and impurity profiling in Brivaracetam formulations.